Class Information

Class Information

Mycoplasma Genitalium (Mgen)
Starting:
1/09/2024
Ending:
1/09/2024
Status:
Closed
Location:
Webinar,
Cost:
FREE
Credit Hours:
1



Sexual Health Update
WCSC4339
Start 11/16/2023

 

AGENDA

TIME

SESSIONS

SPEAKERS

1:00PM-2:00PM  

Mycoplasma Genitalium 

William Geisler MD 

Professor of Medicine 

University of Alabama at Birmingham
   
 
 

This webinar will cover: Mycoplasma genitalium epidemiology, clinical manifestations, diagnosis, resistance. and treatment

 


OBJECTIVES

  1. Describe the importance of interprofessional collaboration in sexual health care.
  2. Describe current STD/HIV screening strategies and diagnostic algorithms.
  3. Describe current STD/HIV treatment recommendations.


ORIGINATION DATE:   June 1, 2022
EXPIRATION DATE:     June 1, 2024        

ACCREDITATION STATEMENTS:

CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and the New York City STD Prevention Training Center. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.

CNE:  The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. 

This activity provides 1 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

 

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies

with the exception of Dr. Geisler and he wishes to disclose relationships with the Hologic, Inc., Sanofi, Abbott and Visby. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Geisler’s discussion on Mgen. He will be discussing salvage therapies for multidrug resistant M.genitalium infection.

The Centers for Disease Control and Prevention and the New York City STD Prevention Training Center are jointly providing the CNE for this activity. 

CDC did not accept commercial support for this continuing education activity. 

Instructions for Obtaining Continuing Education (CE)

In order to receive continuing education (CE) for WCSC4339 Sexual Health Update  please visit TCEO and follow these 9 Simple Steps before February 9 2024.

The course access code is PIDS2024

Complete the activity.
Complete the Evaluation at  www.cdc.gov/GetCE
FEES: There are no fees for CE.   



© 2024 Denver National

A member of the National Network of STD Clinical Prevention Training Centers. The NNPTC registration website is built and maintained by the Denver PTC, a program of Denver Public Health, a department of Denver Health and Hospital Authority. This Website was supported by Cooperative Agreement #5U62PS003282 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.